Thalidomide-NH-C4-NH-Boc
CAS : 2093388-52-2
Ref. 3D-TID38852
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
Thalidomide is a drug that was originally marketed as a sedative and anti-inflammatory agent. It has been shown to inhibit the activity of various enzymes, including protein kinases, phosphatases, and proteases. Thalidomide also acts as an inhibitor of angiogenesis by binding to the TNF receptor on endothelial cells. Thalidomide has been used extensively in research due to its high purity and low cost. This drug is a ligand for the receptor tyrosine kinase (RTK) which may be involved in cell proliferation and differentiation. Thalidomide has been shown to activate this RTK in some instances but inhibit it in others, depending on the specific receptor subtype.